HOME > BUSINESS
BUSINESS
- Takeda to Procure €7.5 Billion in Bonds for Shire Acquisition
November 19, 2018
- AstraZeneca Japan Set to Roll Out 4 New Treatments Every Year through 2021: Chief
November 16, 2018
- Talion AG Contributes to Nipro’s Strong Generic Biz Growth
November 16, 2018
- Novo to Develop New Dosages for Ozempic, 14-Day Prescription Limit Weighs
November 16, 2018
- NapaJen Pharma Initiates PI Trial of Oligonucleotide Therapeutic in Australia
November 16, 2018
- Hib Vaccine Wind-Up, Development Flop Trigger GSK, Daiichi Sankyo to Shutter JV
November 15, 2018
- Meiji Seika Pharma to Venture into Eye-Care Field in Indonesia in Collaboration with Santen
November 15, 2018
- Nichi-Iko Places Top Priority on Product Launches in the US in Biosimilar Business: President
November 14, 2018
- GSK, Daiichi Sankyo Dissolve Vaccine JV
November 14, 2018
- Sumitomo Dainippon Establishes JV with Sumitomo Bakelite through Transfer of Diagnostics Biz
November 13, 2018
- Santen Aims at 1st-Line Use of Eybelis for Glaucoma Treatment: President
November 13, 2018
- Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
November 13, 2018
- Takeda: De-facto Vote on Shire Deal Set for Dec. 5
November 12, 2018
- Japan Is Top Strategic Market for Biogen: CEO
November 12, 2018
- Ethical Drug Sales Down 8.1% in September: Crecon
November 12, 2018
- Avastin Tops Japan Sales Ranking for 3 Months on End: Encise Snapshot
November 12, 2018
- Nippon Kayaku’s Herceptin Biosimilar to Foray into Breast Cancer Arena, following Daiichi Sankyo, Pfizer
November 12, 2018
- Eisai Launches Full-Scale Operations at New China Plant, Doubling Production Capacity
November 12, 2018
- EA Pharma Pairs Up with 6 Institutions on Joint Research on Novel Antibody for Crohn’s Disease
November 9, 2018
- Maviret Retains Top Spot in Japan Drug Ranking in July-September: IQVIA
November 8, 2018
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
